Down-regulation of a polynucleotide encoding a Sou2 sorbitol utilization protein to modify lipid production in microbial cells
View Patent ↗Recombinant microbial cells are disclosed herein that comprise (i) a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein, and (ii) a polyunsaturated fatty acid (PUFA) biosynthetic pathway. The down-regulation of the polynucleotide sequence encoding Sou2 sorbitol utilization protein can increase the lipid content of the microbial cells and/or decrease the total amount of sugar alcohols produced by the microbial cells. Also disclosed are methods of using the recombinant microbial cells to produce oil containing omega-3 polyunsaturated fatty acids such as EPA.
1. A recombinant microbial cell comprising a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein selected from the group consisting of Aspergillus niger, Bifidobacterium dentium, Candida albicans, Candida dubliniensis, Candida orthopsilosis, Candida parapsilosis, Cordyceps militaris, Debaryomyces hansenii, Enterobacter hormaechei, Gaeumannomyces graminis, Glarea lozoyensis, Lodderomyces elongisporus, Magnaporthe oryzae, Metarhizium acridum, Metarhizium anisopliae, Mycobacterium smegmatis, Neurospora crassa, Neurospora tetrasperma, Paracoccidioides brasiliensis, Penicillium chrysogenum, Scheffersomyces stipitis, Uncinocarpus reesii, Verticillium dahliae , and Yarrowia lipolytica , wherein said down-regulation decreases the total amount of sugar alcohols produced by the microbial cell, as compared to a suitable control cell.
2. The recombinant microbial cell of claim 1 , wherein said down-regulation is due to a mutation of said endogenous polynucleotide sequence.
3. The recombinant microbial cell of claim 2 , wherein said mutation is selected from the group consisting of a substitution, deletion and insertion.
4. The recombinant microbial cell of claim 3 , wherein said mutation is a deletion that removes
(i) one or more nucleotides from an open reading frame encoding said Sou2 sorbitol utilization protein, and/or
(ii) one or more nucleotides of a non-protein-coding sequence located within 500 base pairs of the 5′-end of said open reading frame.
5. The recombinant microbial cell of claim 3 , wherein said mutation is an insertion that occurs within
(i) an open reading frame encoding said Sou2 sorbitol utilization protein, or
(ii) a non-protein-coding sequence located within 500 base pairs of the 5′-end of said open reading frame.
6. The recombinant microbial cell of claim 1 , wherein said sugar alcohols comprise arabitol or mannitol.
7. The recombinant microbial cell of claim 1 , wherein said microbial cell is an oleaginous yeast cell.
8. The recombinant microbial cell of claim 7 , wherein said oleaginous yeast is a Yarrowia lipolytica cell.
9. The recombinant microbial cell of claim 8 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:10.
10. The recombinant microbial cell of claim 8 , wherein said endogenous polynucleotide sequence comprises a nucleotide sequence that is at least 95% identical to SEQ ID NO:9.
11. The recombinant microbial cell of claim 1 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 90% identical to SEQ ID NO:10.
12. The recombinant microbial cell of claim 11 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:10.
13. The recombinant microbial cell of claim 12 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 98% identical to SEQ ID NO:10.